Evaluation of omega-3 fatty acids in biliary atresia patients

Evaluation of omega-3 fatty acids in biliary atresia patients - Evaluation of omega-3 fatty acids in biliary atresia patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009165

Enrollment

Registered

2012-12-01

Start date

2012-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

biliary atresia

Interventions

omegaven

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: biliary atreisa

Exclusion criteria

Exclusion criteria: non

Design outcomes

Primary

Measure	Time frame
jaundice disappeared or not duration of jaundice disappearance laboratory data of liver function (preoperation, postoperation 1w, 2w, 4w, 6w, 8w) fatty acids fraction (preoperation, postoperation 1w, 2w, 4w, 6w, 8w)	—

Countries

Japan

Contacts

Public ContactHideyuki Sasaki

Tohoku University Hospital

022-717-7237

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026